It has long been appreciated that the measurement of biochemical parameters
for prenatal screening for neural tube defects, and later aneuploidy, is n
ot as simple as measuring hemoglobin or hematocrit. Early in the game, it w
as recognized that there are gestational age curves, and that since a-fetop
rotein (AFP), for example, is a fetal product, its distribution varies as a
function of maternal plasma volume, and therefore the weight of the mother
. A number of different adjustment factors have been used for AFP and other
parameters for years, with varying degrees of consistency and reliability.
Here we review a number of adjustments that have been used, and try to giv
e priority to those that have been most effective. Furthermore, laboratorie
s and programs need to be cognizant that with newer pa ra meters bei ng add
ed, the specifics of requirements will vary on a case-by-case parameter bas
is, and optimal screening can only be achieved with the appropriate adjustm
ents.